You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 114 No. 5, May 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  LABORATORY SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Effects of Corticosteroids on Adenoviral Replication

Eric G. Romanowski, MS; Laurie A. Roba, MD; Lee Wiley, MD; Trinita Araullo-Cruz, PhD; Y. Jerold Gordon, MD

Arch Ophthalmol. 1996;114(5):581-585.


Abstract



Objective
To evaluate the effects of Pred Forte (prednisolone acetate; Allergan Pharmaceutical, Irvine, Calif) on the replication of different adenoviral serotypes in vitro and in the adenovirus type 5/New Zealand rabbit ocular model.

Methods
The 50% inhibitory doses of Pred Forte and its components were determined for common ocular serotypes. The effects of continuous topical treatment with Pred Forte for 18 days were evaluated (eg, conjunctivitis, subepithelial immune infiltrates, and serial ocular viral titers) in the adenovirus 5/New Zealand rabbit ocular model.

Results
Pred Forte and prednisolone acetate inhibited adenoviruses 1, 5, 8, and 19 in vitro. In vivo, 1% Pred Forte significantly reduced conjunctivitis (P=.04) and subepithelial infiltrates (P=.02), but enhanced viral replication (P=.01) on days 9 to 21 and increased the duration of viral shedding (P<.001).

Conclusions
Despite demonstrated anti-inflammatory and anti-immune effects, prolonged treatment of acute adenoviral infections with topical Pred Forte is not recommended because of the enhanced risks of viral transmission and community epidemics.



Author Affiliations



From the Campbell Laboratory for Infectious Eye Diseases, Department of Ophthalmology, University of Pittsburgh (Pa) School of Medicine. The authors have no proprietary interest in the companies or products mentioned in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical and Antiviral Efficacy of an Ophthalmic Formulation of Dexamethasone Povidone-Iodine in a Rabbit Model of Adenoviral Keratoconjunctivitis
Clement et al.
IOVS 2011;52:339-344.
ABSTRACT | FULL TEXT  

The In Vitro and In Vivo Evaluation of ddC as a Topical Antiviral for Ocular Adenovirus Infections
Romanowski et al.
IOVS 2009;50:5295-5299.
ABSTRACT | FULL TEXT  

Effects of Diclofenac or Ketorolac on the Inhibitory Activity of Cidofovir in the Ad5/NZW Rabbit Model
Romanowski and Gordon
IOVS 2001;42:158-162.
ABSTRACT | FULL TEXT  

Efficacy of Topical Cidofovir on Multiple Adenoviral Serotypes in the New Zealand Rabbit Ocular Model
Romanowski and Gordon
IOVS 2000;41:460-463.
ABSTRACT | FULL TEXT  

The Effects of Topical Nonsteroidal Anti-inflammatory Drugs on Adenoviral Replication
Gordon et al.
Arch Ophthalmol 1998;116:900-905.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.